Patricia Ault

1.2k total citations
25 papers, 871 citations indexed

About

Patricia Ault is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Patricia Ault has authored 25 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 14 papers in Genetics and 9 papers in Rheumatology. Recurrent topics in Patricia Ault's work include Chronic Myeloid Leukemia Treatments (22 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Eosinophilic Disorders and Syndromes (9 papers). Patricia Ault is often cited by papers focused on Chronic Myeloid Leukemia Treatments (22 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Eosinophilic Disorders and Syndromes (9 papers). Patricia Ault collaborates with scholars based in United States, United Kingdom and Italy. Patricia Ault's co-authors include Jörge E. Cortes, Hagop M. Kantarjian, Charles Koller, Mary Beth Rios, Richard Pilot, Alan K. Hatfield, Gianantonio Rosti, Jane F. Apperley, Susan O’Brien and Francis J. Giles and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia Research.

In The Last Decade

Patricia Ault

25 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia Ault United States 9 573 446 294 239 230 25 871
Eduardo Bullorsky Argentina 13 746 1.3× 335 0.8× 558 1.9× 123 0.5× 163 0.7× 34 955
J P Jouet France 16 784 1.4× 103 0.2× 292 1.0× 302 1.3× 172 0.7× 26 991
Kirsten Merx Germany 11 423 0.7× 254 0.6× 351 1.2× 82 0.3× 140 0.6× 35 692
Nathalie Cambier France 14 615 1.1× 297 0.7× 725 2.5× 74 0.3× 235 1.0× 41 1.1k
Haefaa Alchalby Germany 19 914 1.6× 272 0.6× 665 2.3× 100 0.4× 116 0.5× 32 1.1k
Marzia Salvucci Italy 15 289 0.5× 51 0.1× 272 0.9× 146 0.6× 214 0.9× 27 716
Jolanta B. Perz Germany 14 396 0.7× 141 0.3× 154 0.5× 191 0.8× 154 0.7× 27 795
Anand P. Jillella United States 15 485 0.8× 47 0.1× 222 0.8× 101 0.4× 280 1.2× 55 866
Agnès Guerci‐Bresler France 18 1.4k 2.4× 546 1.2× 1.1k 3.9× 111 0.5× 237 1.0× 53 1.5k
Luigiana Luciano Italy 14 430 0.8× 154 0.3× 294 1.0× 48 0.2× 80 0.3× 32 622

Countries citing papers authored by Patricia Ault

Since Specialization
Citations

This map shows the geographic impact of Patricia Ault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Ault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Ault more than expected).

Fields of papers citing papers by Patricia Ault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Ault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Ault. The network helps show where Patricia Ault may publish in the future.

Co-authorship network of co-authors of Patricia Ault

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Ault. A scholar is included among the top collaborators of Patricia Ault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Ault. Patricia Ault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ault, Patricia, et al.. (2016). Bosutinib Therapy in Patients With Chronic Myeloid Leukemia: Practical Considerations for Management of Side Effects. Journal of the Advanced Practitioner in Oncology. 7(2). 160–175. 7 indexed citations
2.
Williams, Loretta A., Qiuling Shi, Patricia Ault, et al.. (2016). Symptom Severity Cut Points for the MD Anderson Symptom Inventory for CML (MDASI-CML). Blood. 128(22). 4765–4765. 1 indexed citations
3.
Ault, Patricia, Hagop M. Kantarjian, Guillermo Garcia‐Manero, et al.. (2013). Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS). Blood. 122(21). 2988–2988. 5 indexed citations
4.
Williams, Loretta A., Araceli García-González, Patricia Ault, et al.. (2013). Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood. 122(5). 641–647. 88 indexed citations
5.
Ault, Patricia. (2012). Dasatinib in the first-line treatment of chronic myeloid leukemia. Community Oncology. 9(11). 336–343. 1 indexed citations
6.
Rios, Mary Beth & Patricia Ault. (2011). Identification of Side Effects Associated With Intolerance to BCR-ABL Inhibitors in Patients With Chronic Myeloid Leukemia. Clinical journal of oncology nursing. 15(6). 660–667. 8 indexed citations
7.
Williams, Loretta A., Patricia Ault, Araceli García-González, et al.. (2011). Identifying High Symptom Burden in Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitor Therapy. Blood. 118(21). 3138–3138. 1 indexed citations
8.
Williams, Loretta A., Araceli García-González, Patricia Ault, et al.. (2010). Symptom Burden In Patients with Chronic Myeloid Leukemia (CML) on Kinase Inhibitor (KI) Therapy.. Blood. 116(21). 3838–3838. 3 indexed citations
9.
Williams, Loretta A., Jörge E. Cortes, Patricia Ault, et al.. (2010). Including Patient Input In Patient-Reported Outcome Instrument Development: Examples From the MDASI-CML. Blood. 116(21). 2573–2573. 3 indexed citations
10.
Ault, Patricia & Karen L. Jones. (2009). Understanding Iron Overload. Clinical journal of oncology nursing. 13(5). 511–517. 14 indexed citations
11.
Cole, Suzanne, Hagop M. Kantarjian, Patricia Ault, & Jörge E. Cortes. (2009). Successful Completion of Pregnancy in a Patient With Chronic Myeloid Leukemia Without Active Intervention: A Case Report and Review of the Literature. Clinical Lymphoma & Myeloma. 9(4). 324–327. 38 indexed citations
12.
Williams, Loretta A., Patricia Ault, Xin Shelley Wang, et al.. (2008). The Symptom Burden of Chronic Myelogenous Leukemia (CML). Blood. 112(11). 2408–2408. 5 indexed citations
13.
Cortes, Jörge E., Susan O’Brien, Patricia Ault, et al.. (2008). Pregnancy Outcomes among Patients with Chronic Myeloid Leukemia Treated with Dasatinib. Blood. 112(11). 3230–3230. 33 indexed citations
14.
Cortes, Jörge E., Patricia Ault, Alan K. Hatfield, et al.. (2008). The effects of imatinib on pregnancy outcome. Blood. 111(12). 5505–5508. 251 indexed citations
15.
Ault, Patricia. (2007). Overview of Second-Generation Tyrosine Kinase Inhibitors for Patients With Imatinib-Resistant Chronic Myelogenous Leukemia. Clinical journal of oncology nursing. 11(1). 125–129. 8 indexed citations
16.
Ault, Patricia, Hagop M. Kantarjian, Susan O’Brien, et al.. (2006). Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib. Journal of Clinical Oncology. 24(7). 1204–1208. 162 indexed citations
17.
Ault, Patricia, Hagop M. Kantarjian, Mary Alma Welch, et al.. (2004). Interleukin 11 May improve thrombocytopenia associated with Imatinib mesylate therapy in chronic Myelogenous leukemia. Leukemia Research. 28(6). 613–618. 17 indexed citations
18.
Ault, Patricia, et al.. (2003). Management of Molecular‐Targeted Therapy for Chronic Myelogenous Leukemia. Journal of the American Academy of Nurse Practitioners. 15(7). 292–296. 5 indexed citations
19.
Cortes, Jörge E., Patricia Ault, Charles Koller, et al.. (2003). Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood. 101(12). 4714–4716. 115 indexed citations
20.
Ault, Patricia, et al.. (2002). Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate. Leukemia Research. 26(9). 881–884. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduardo Bullorsky Breakdown of academic impact, for papers by J P Jouet Breakdown of academic impact, for papers by Kirsten Merx Breakdown of academic impact, for papers by Nathalie Cambier Breakdown of academic impact, for papers by Haefaa Alchalby Breakdown of academic impact, for papers by Marzia Salvucci Breakdown of academic impact, for papers by Jolanta B. Perz Breakdown of academic impact, for papers by Anand P. Jillella Breakdown of academic impact, for papers by Agnès Guerci‐Bresler Breakdown of academic impact, for papers by Luigiana Luciano
Rankless by CCL
2026